Newsfilterยท2024-02-01 08:30Core Viewpoint - HUTCHMED (China) Limited is set to announce its final results for the year ended December 31, 2023, on February 28, 2024, indicating a significant upcoming event for investors and analysts [1]. Group 1: Financial Results Announcement - The final results announcement will occur at 6:30 am EST / 11:30 am GMT / 7:30 pm HKT on February 28, 2024 [1]. - A conference call and audio webcast presentation with Q&A will follow the results announcement, scheduled for 7:30 am EST / 12:30 pm GMT / 8:30 pm HKT on the same day [2]. Group 2: Company Overview - HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases [3]. - The company employs approximately 5,000 personnel, with a core team of about 1,800 dedicated to oncology and immunology [3]. - HUTCHMED has successfully brought three cancer drug candidates to market in China, with the first also marketed in the U.S. [3].